Ratio of Thyrotropin to Thyroglobulin as a Novel Marker for Differentiating Between Benign and Malignant Thyroid Nodules within Different Bethesda Categories

TAM A. A., ÖZDEMİR D., AYDIN C., BİLGİNER M. C., YAZICIOĞLU M. Ö., SÜNGÜ N., ...More

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.22, no.1, pp.21-31, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.25179/tjem.2017-58803
  • Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.21-31
  • Keywords: Thyrotropin, thyroglobulin, thyroid malignancy, TSH/Tg, Bethesda, PREOPERATIVE SERUM THYROGLOBULIN, STIMULATING HORMONE-LEVEL, FINE-NEEDLE-ASPIRATION, CANCER, CYTOPATHOLOGY, SYSTEM, PREDICTION
  • Karadeniz Technical University Affiliated: No

Abstract

Objective: We aimed to determine whether the ratio of thyrotropin (TSH) to thyroglobulin (Tg) (TSH/Tg) would be able to assist in predicting malignancy in thyroid nodules.